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Abstract Intracellular pathogens selected for increased
susceptibility to polycations are commonly attenuated,
yet the effect of decreased susceptibility to polycations
on pathogenicity has not been researched. The poly-
myxin-resistant mutant Brucella abortus AJ100 was
characterized by comparing its susceptibility to the
polycationic antibiotic polymyxin B, defensins, and lac-
toferricin, and its colonization and clearance in the
mouse model to the parent strain RB51. MIC (minimum
inhibitory concentration) values determined by Etest for
AJ100 and RB51 were 1.5 and 0.25 lg/ml, respectively.
Though AJ100 is less susceptible to polymyxin B than
RB51, it was more susceptible than its parent strain to
the cationic defensins melittin, magainin 2, and cecropin
P1. In the mouse model, initial colonization of the spleen
was lower for AJ100 than RB51, and the rate of clear-
ance from the spleen was faster for AJ100 than RB51.
However, initial colonization and clearance rates of
AJ100 from the liver were indistinguishable from those
of RB51. This study suggests that the susceptibility
proﬁle of Brucella to polycationic defensins rather than
polymyxin B may be indicative of differential survival in
the spleen and liver in the mouse and is indicative of
spleen and liver residential macrophages’ differing ability
to inactivate Brucella.
Introduction
Brucella is a facultative intracellular Gram-negative bac-
terium that causes food animal losses due to reproductive
failure and is transmitted to humans primarily through
contact with infected animals at parturition and through
consumption of contaminated, unpasteurized milk and soft
cheeses. Brucella persists in infected animals, surviving in
macrophages even though these cells possess an arsenal of
compounds including polycationic antimicrobial peptides
of innate immune systems designated ‘‘defensins’’ that aid
in destroying engulfed bacteria.
The outer membranes (OM) of Gram-negative bacteria
are composed chieﬂy of lipid A containing LPS and are a
target of polycationic compounds such as polymyxin B and
defensins [4, 6, 15, 22]. Bacteria with a smooth colony are
less susceptible to polymyxin B than their mutants that
have a rough colony phenotype, which have reduced
binding polycations including polymyxin B [1, 4, 16]. Few
studies report the susceptibility of Brucella to polymyxin B
as minimum inhibition concentration (MIC) values, but the
relative susceptibility of Brucella strains appears consistent
across studies [7, 8, 16]. RB51, a rough B. abortus vaccine
strain, plates with an efﬁciency of 15% on medium con-
taining 1.8 U/ml polymyxin B. A mutant of this strain,
RB51/HP [10], herein designated ‘‘AJ100,’’ grows in the
presence of 1.8 U/ml of polymyxin B. Comparative MIC
values have not been reported for either AJ100 or RB51.
Brucella are relatively less sensitive to polymyxin B and
other polycationic compounds than Salmonella; likely both
LPS and outer membranes play a role [4, 5, 7, 15, 16, 23].
Mutants of the facultative intracellular pathogens Salmo-
nella and Brucella with increased susceptibility to
polymyxin B are attenuated and usually exhibit increased
susceptibility to other polycationic compounds as well [1,
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susceptible mutant strain 65.21 (herein designated
‘‘SBvrR’’), which has a smooth phenotype, is also more
susceptible than the parent strain to the defensin mellitin
and the polycation poly-L-lysine [19]. How the decreased
sensitivities to polymyxin B and mellitin are linked in
SBvrR has not been investigated. Further, it is not known if
decreased susceptibility to the defensin mellitin alone
would attenuate Brucella. Mutants with decreased sus-
ceptibility to polymyxin B would be predicted to exhibit
decreased susceptibility to other polycations, but this has
not been explored.
Mice are used extensively as experimental animals to
study the pathogenicity and persistence of Brucella. They
persist in the murine immune system, concentrating in the
spleen and liver, and are observed in macrophages despite
these cells’ expressing defensins [9]. Following intraperito-
neal injection (i.p.), colonization of the spleen and liver of
Brucella is determined by plate counts over several months.
High numbers of 2308, the vaccine challenge strain, are
maintained in the spleens of BALB/c mice at 100 days [21],
while RB51 iseliminated from BALB/cmice between 4and
8 weeks [20]. Subcutaneous injection of the smooth poly-
myxinB-sensitiveB.abortus2308mutantSBvrRwasfound
to be severely attenuated in the mouse model, scarcely rep-
licating,ifatall,inmice.Brucellawereclearedfrom50%of
themiceby35dayswhengivenRB51andby175dayswhen
given the parent strain 2308 [19].
Here we determine the MIC value for the mutant AJ100
relative to other strains which exhibit susceptibility to
polymyxin B, proﬁle the susceptibility of AJ100 to poly-
cationic compounds, and explore the correlation between
phenotype regarding susceptibility to polycationic com-
pounds and virulence in the mouse model relative to the
parent strain RB51.
Materials and Methods
Brucella Strains
Brucella abortus RB51 (RB51) vaccine strain [18], B.
abortus RB51/HP (AJ100) [10], B. abortus 65.21(SBvrR)
[19], and B. abortus 2308 (2308), a common B. abortus
challenge strain, used in this study were obtained from the
National Animal Disease Center (ARS/USDA, Ames, IA)
culture collection.
Sensitivity to Polycationic Compounds
In vitro activity of polymyxin B was determined by the
Etest (AB Biodisk, Piscataway, NJ) containing a preformed
gradient covering a continuous MIC range (0.064–1024 lg/
ml) corresponding to 15 twofold dilutions of polymyxin B
with a precision of 0.5 dilution. Brucella were suspended in
saline and the turbidity was adjusted to a 0.5 McFarland
standard (5 9 10
8 colony-forming units [CFU]/ml). The
suspension was spread onto Mueller Hinton (MH; Difco
Laboratories, Detroit, MI) or pH-adjusted MH agar plates
using a cotton swab, and the Etest strips applied. Medium
pH values were adjusted prior to autoclaving. Plates were
incubated (37) in ambient air or in an atmosphere of 7.5%
CO2. Results were read after 48 h.
Aqueous solutions of defensins were dropped (1, 2, and
4 ll) onto cultures swabbed as described above to assay
strain susceptibility. Stock solutions of the polycationic
compounds were prepared as follows: melittin, honeybee
venom (10 lg/ll; Sigma Chemical Company, St. Louis,
MO), magainin 2, frog skin (1 lg/ll; American Peptide
Company [APC], Sunnyvale, CA); lactoferricin, bovine (1
lg/ll; APC); bactenecin, bovine (2 lg/ll; APC); and
cecropin P1, porcine (1 lg/ll; APC). Plates were incubated
at 37C and results were recorded after 48 h. A strain
showing no inhibition of growth was recorded as resistant
(R). If a zone of no growth was noted, the strain was
designated susceptible (S). If a zone of nonconﬂuent
growth was noted at the drop point, the strain was desig-
nated intermediate (I).
Animal Inoculation
Female 10-week-old BALB/c AnNHsD mice (Harlan
Sprague Dawley, Indianapolis, IN) were used. Mice
(n = 25/treatment [trt]) were inoculated intraperitoneally
with 0.2 ml of saline or 0.2 ml of saline containing
1 9 10
7 CFU of B. abortus strain AJ100 or strain RB51.
Five mice each from the saline control, AJ100, and RB51
groups were euthanized with CO2/O2 at 1, 2, 3, 4, and 8
weeks postinoculation (PI). Spleens and livers were
weighed and processed for determination of Brucella
CFU.
Culture Examination of Spleen and Livers
Spleens and livers were homogenized in tissue grinders,
serially diluted in saline, and plated on tryptose agar
(Difco) containing 5% bovine serum (TSA). After incu-
bation of plates at 37C with 7.5% CO2 for 72 h, numbers
of CFU were determined for each dilution by standard plate
counts. Colonies were conﬁrmed as Brucella based on
colony morphology, growth characteristics [2], and a
Brucella-speciﬁc polymerase chain reaction (PCR) proce-
dure as described, previously [13].
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For statistical comparisons, colonizations of spleen and
liver (CFU/g and total CFU/tissue) were analyzed as the
logarithm of their value. Due to conversion to logarithm,
any colonization data with a value of 0 were analyzed with
a value of 1. Statistical differences between treatments
were determined by a general linear models procedure, and
signiﬁcant differences were reported when p\0.05.
Means for each treatment were compared by use of a least
signiﬁcant difference procedure and are reported as least
square mean ± SE.
Results
Susceptibility to Polymyxin B
Etest MIC values of B. abortus strains AJ100 and RB51
differed by sixfold in the presence of 7.5% CO2. MIC
values were 1.5 and 0.25 lg/ml, respectively (Fig. 1). In
general as the pH became more acidic, the Brucella strains
were less susceptible to polymyxin B. However, RB51 was
less susceptible at pH 5 than at pH 6. AJ100 did not grow at
pH 5.
Susceptibility to Defensins
Brucella strains were examined for susceptibility to
defensins in a drop assay (Table 1). The parent strain of
RB51, 2308, was not susceptible to any of the defensins at
the concentrations applied. RB51 was susceptible or par-
tially susceptible to two of the defensins, mellitin and
cecropin P1, respectively, but only in the presence of CO2.
Among the Brucella strains studied, the pattern of sus-
ceptibility to the defensins was most similar between
AJ100 and SBvrR. Both AJ100 and SBvrR were shown to
be more susceptible to the defensins mellitin and cecropin
P1than their parent strains, RB51 and 2308, respectively.
AJ100 was also sensitive to magainin 2, but only in
ambient air. None of the strains used in this study were
susceptible to either bactenecin or lactoferricin at 8 and
4 lg, respectively (data not shown).
Tissue Persistence in a Mouse Model
RB51-infected mice had greater (p\0.05) splenic colo-
nization (CFU/g and total CFU) at 1, 2, 3, and 4 weeks PI
than AJ100-inoculated mice (Fig. 2). Liver colonization
did not differ (p[0.05) between mice given RB51 versus
AJ100. Both RB51 and AJ100 were recovered from spleens
and livers of injected mice at 4 weeks but not at 8 weeks.
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Fig. 1 MIC values of B. abortus strains AJ100 (cross-hatch) and
RB51 parent strain (black) for polymyxin B at pH values from pH 5 to
pH 8.0. Cultures were grown in the presence of CO2
Table 1 Susceptibility
a of Brucella abortus strains to defensins
Brucella strain
b Melittin Magainin 2 Cecropin P1
10 lg4 0 lg1 lg4 lg1 lg2 lg4 lg
RB51 A R R R R R R R
RB51 C S S R R R R I
AJ100 A S S S S S S S
AJ100 C S S R R S S S
2308 A R R R R R R R
2308 C R R R R R R R
SBvrR A S S R R S S S
SBvrR C S S R R S S S
a R, resistant; S, susceptible; I, intermediate
b A—grown in ambient air; C—grown in the presence of added CO2
Fig. 2 Colonization of splenic (A) and hepatic (B) tissues (mean
log10 total CFU per tissue ± SE) after intraperitoneal inoculation
(n = 25 mice/treatment [trt]) with 1 9 10
7 CFU of B. abortus strains
RB51 (black columns) or AJ100 (cross-hatched columns). Means
with different superscripts differ signiﬁcantly (p B 0.05) for that
tissue
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mice were determined (Table 2). Compared to control
mice, spleen weights were greater in mice inoculated with
RB51 or AJ100 at 1, 2, 3, and 4 weeks, but not at 8 weeks
PI. Compared to AJ100-inoculated mice, RB51-inoculated
mice had greater (p\0.05) spleen weights only at 2 and 3
weeks PI. In contrast, liver weights of both RB51 and
AJ100 were greater than that of control mice only at week
1 PI. Liver weights between AJ100- and RB51-inoculated
mice were signiﬁcantly different (p[0.05) only at week 2
PI. No statistical difference in weights of spleens or livers
among any of the treatment groups was detected at 8 weeks
PI.
Discussion
The Etest was used to determine relative MIC values of
Brucella strains for polymyxin B. It is easily conducted and
gave relative results similar to those reported using more
time-consuming and complex protocols, such as viability
tests with time or dilution end points. Though both 2308
and SBvrR are smooth and less susceptible to polymyxin B
than RB51 and AJ100, we found similar-fold differences in
polymyxin B susceptibility between the mutants and their
parents. The MIC value for SBvrR (16 IU/ml) is eightfold
lower than that for the parent strain 2308 (128 IU/ml) in a
microtiter plate format growth assay [19], and, by the Etest,
the MIC values were fourfold lower, with values of 6 and
24 lg/ml, respectively [11]. The differences observed are
likely due not only to protocol differences but also to the
higher precision of the Etest. This assay has a precision of
0.5 dilutions, as opposed to twofold dilutions for many
other commonly used protocols.
Growth of Brucella slightly increases the pH of many
bacterial culture media though absorption of CO2 acidiﬁes
it. As the medium acidiﬁes, there is a concurrent reduction
in antimicrobial activity of cations due to a reduction in its
charge. However, in the case of AJ100 susceptibility to
maganin was less when cultured in the presence of CO2
than in ambient air. Screening of mutants for change in
polycationic susceptibility will need to be carried out in the
presence of CO2 even if the strains studied are CO2 inde-
pendent or a class of mutants is likely to be missed.
The target or locus resulting in increased sensitivity to
mellitin either does not cause susceptibility to polymyxin B
or has the opposite effect. Characterization of the Brucella
BvrR/BvrS mutants has begun and the effect of several loci
and likely mechanisms are emerging [14, 15]. As BvrR/
BvrS compose a two-component system which enables
bacteria to quickly and speciﬁcally respond to environ-
mental changes by globally modulating and coordinating
expression of many gene products affecting different
functional pathways, many loci may be involved, espe-
cially given that BvrR/BvrS may regulate other two-
component systems. Identiﬁcation of loci involved in the
disparate susceptibility of AJ100 to the polycationic com-
pounds polymyxin B and mellitin via microarray and other
studies could identify speciﬁc loci for further study.
Attenuated intracellular bacterial pathogens have been
identiﬁed by screening for increased susceptibility to
polymyxin B. This predicts that increased resistance to
polycations would increase pathogenicity. However, this
was not found to be the case for AJ100. The observed
discordance between susceptibility of AJ100 to polymyxin
B and mellitin that we observed relative to SBvrR was
resolved by determination of the relative pathogenicity of
AJ100 to colonize and persist in a murine model compared
to the parent strain. Increased susceptibility of AJ100 to the
defensins mellitin, maganin, and cecropin correlated
directly with attenuation in the spleen.
Attenuation of AJ100 relative to RB51 was observed in
the spleen (Fig. 2) but not the liver. This attenuation may
be dependent on differences in polycationic content
between spleen and liver resident macrophages, as it has
been shown that defensin expression by the innate immune
system affects tissue colonization. Transgenic mice
expressing a human intestinal defensin were protected from
infection by Salmonella typhimurium [17], which other-
wise is quite deadly to mice. As the defensins used in this
study were isolated from higher organisms, unlike poly-
myxin B, which comes from bacteria, the proﬁles of
Table 2 Spleen and liver weights postinoculation (PI)
Weeks PI Spleen weight (mg) Liver weight (mg)
RB51 AJ100 Control RB51 AJ100 Control
1 166 ± 38
a 168 ± 8
a 82 ± 7
b 1062 ± 105
a 1142 ± 123
a 856 ± 61
b
2 162 ± 29
a 124 ± 4
b 87 ± 5
c 920 ± 72
ab 938 ± 98
a 838 ± 78
b
3 121 ± 17
a 100 ± 12
b 81 ± 10
c 1085 ± 65
a 1083 ± 35
a 985 ± 32
b
4 125 ± 16
a 112 ± 10
ab 99 ± 2
b 1024 ± 88
a 1006 ± 58
a 1010 ± 45
a
Note. Weights are recorded as the mean ± SE. Means with different superscripts differ signiﬁcantly (p B 0.05) among treatments for that tissue
per sampling time
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uation for intracellular bacteria than susceptibility to
polymyxin B.
In summary, AJ100 is sixfold more resistant to poly-
myxin B than the parental RB51 strain as determined by
the Etest. Though AJ100 was less susceptible to this
polycationic antibiotic than its parent strain, it was more
susceptible to the cationic defensins, mellitin, maganin,
and cecropin. This proﬁle correlated with attenuation of
AJ100 in the mouse model. AJ100 did not colonize mice
spleens to the same extent as RB51 and was cleared from
the spleen faster. On the other hand, livers were colonized
and cleared similarly by these two strains. The proﬁle of
susceptibility to defensins may predict attenuation better
than susceptibility to polymyxin B.
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